Janssen E, Vass C, Levitan B, Hauber B, Bent R, King-Kallimanis B. Effective patient engagement in patient experience data: practical insights from case studies in hard-to-reach populations. Presentation to be given at the Drug Information Association (DIA) 2024 Global Annual Meeting; June 18, 2024. San Diego, CA.
Cook C, Carrico J, Talbird S, Gountas I, Skroumpelos A, Boutselakou E, Trimis G, Sabale U, Bencina G. Public health and economic impact of pediatric immunization program in Greece. Presented at the 42nd Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID) 2024; May 24, 2024. Copenhagen, Denmark.
Herring WL, Cole A, Phelps CE, Jiao B. Value assessment and reimbursement of early treatment for prevention in chronic progressive diseases: are traditional approaches up to the task? Presented at the ISPOR 2024; May 7, 2024. Atlanta, GA.
Wolowacz S, Lloyd A, Doward L, Hawe E. Estimating health-state utility for economic models in clinical trials and real-world studies. Presented at the ISPOR 2024; May 5, 2024. Atlanta, GA.
Gnanasakthy A, Crawford R, Qin S, Rockwood N, Doward L. Advanced patient-reported outcomes. Presented at the ISPOR 2024; May 5, 2024.
Rao S, Forns J, Danysh HE, Calingaert B, Dempsey C, Aquilina T, Pathak S, Anthony MS, Layton JB. Natural history and clinical outcomes in patients with Alzheimer's disease-related psychosis in the United States. Presented at the International Conference on Alzheimer's and Parkinson's Diseases (AD/PD) 2024; March 5, 2024. Lisbon, Portugal.
Garcia de Albeniz Martinez X. Analysis methods - casual inference. Presented at the National Academies Board on Health Sciences Policy; February 7, 2024.
Ghaswalla P, Carrico J, Hicks KA. The annual economic burden of respiratory syncytial virus in adults in the United States. Presented at the 2024 Biomedical Advanced Reseaerch and Development Authority George Risi Memorial Journal Club; January 22, 2024.
Earnshaw S, Paret K. The role of operations research in access to pharmaceuticals. Presented at the NC State Operations Research Seminar Series; January 22, 2024. Raleigh, NC.
Anthony MS. Ert/hrt: the new and old conundrums. Presented at the 17th World Congress on Fertility and Sterility; November 25, 2001. Melbourne, Australia.
Irish WD, Neighbors DM, Lopez RB. Using propensity scores to adjust for treatment selection bias: review of methods plus an extension for use in studies with three or more treatment groups. Presented at the 2001 ISPOR 4th Annual European Congress; November 11, 2001. Cannes, France.
Anthony MS, Blair RM, Clarkson TB. Neither isoflavones nor the alcohol-extracted fraction added to alcohol-washed soy protein isolate restores the lipoprotein effects of soy protein isolate. Presented at the Fourth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease; November 4, 2001. San Diego, CA.
Poulos C, Smith VK. A preliminary analysis of economic factors affecting childhood asthma. Presented at the Add Health Users Workshop. National Institutes of Health; August 2001. Bethesda, MD.
Anthony MS. Health effects of soy isoflavonoids. Presented at the 3rd International Conference on Natural Antioxidants and Anticarcinogens in Food Health and Disease; June 6, 2001. Helsinki, Finland.
Hauber AB, Bala MV, Fehnel SE. Conducting cost-benefit and cost-utility analysis: a conjoint analysis approach. Presented at the Annual Meetings of the International Society of Pharmacoeconomics and Outcomes Research; May 2001.
Anthony MS. Soy and cardiovascular disease. Presented at the 11th World Congress of Food Science and Technology; April 22, 2001. Seoul, South Korea.
Leidy NK, Jonas D, Margolis MK, Heyes AE, Jones K, Silberman C. On health-related quality of life, symptoms and the complementary nature of two patient-reported outcomes. Presented at the Drug Information Association Symposium of Contributed Papers on Quality of Life Evaluation; March 2001. Hilton Head, SC.
Arana JI, Jarén C, Arana A, Arazuri S. Detección de nectarinas lanosas mediante impacto no destructivo. Presented at the 1º Congreso Nacional de Ingeniería para la agricultura y el medio rural; 2001.
Pladevall-Vila M. Relationships between obesity, cardiovascular risk factors and insulin resistance. Presented at the European Congress on Clinical Investigation; 2001.
Anthony MS, Crouse JR. Heterogeneity in plasma lipoprotein response to dietary fish oil. Presented at the 8th International Symposium on Atherosclerosis; October 1988. Rome, Italy.